Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 2
2004 3
2005 3
2006 2
2007 4
2008 6
2009 10
2010 11
2011 12
2012 9
2013 6
2014 11
2015 9
2016 11
2017 21
2018 25
2019 25
2020 43
2021 41
2022 22
2023 29
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

273 results

Results by year

Filters applied: . Clear all
Page 1
The dietary sweetener sucralose is a negative modulator of T cell-mediated responses.
Zani F, Blagih J, Gruber T, Buck MD, Jones N, Hennequart M, Newell CL, Pilley SE, Soro-Barrio P, Kelly G, Legrave NM, Cheung EC, Gilmore IS, Gould AP, Garcia-Caceres C, Vousden KH. Zani F, et al. Among authors: jones n. Nature. 2023 Mar;615(7953):705-711. doi: 10.1038/s41586-023-05801-6. Epub 2023 Mar 15. Nature. 2023. PMID: 36922598 Free PMC article.
Circulating white blood cell traits and colorectal cancer risk: A Mendelian randomisation study.
Constantinescu AE, Bull CJ, Jones N, Mitchell R, Burrows K, Dimou N, Bézieau S, Brenner H, Buchanan DD, D'Amato M, Jenkins MA, Moreno V, Pai RK, Um CY, White E, Murphy N, Gunter M, Timpson NJ, Huyghe JR, Vincent EE. Constantinescu AE, et al. Among authors: jones n. Int J Cancer. 2024 Jan 1;154(1):94-103. doi: 10.1002/ijc.34691. Epub 2023 Aug 14. Int J Cancer. 2024. PMID: 37578112
Canagliflozin impairs T cell effector function via metabolic suppression in autoimmunity.
Jenkins BJ, Blagih J, Ponce-Garcia FM, Canavan M, Gudgeon N, Eastham S, Hill D, Hanlon MM, Ma EH, Bishop EL, Rees A, Cronin JG, Jury EC, Dimeloe SK, Veale DJ, Thornton CA, Vousden KH, Finlay DK, Fearon U, Jones GW, Sinclair LV, Vincent EE, Jones N. Jenkins BJ, et al. Among authors: jones n. Cell Metab. 2023 Jul 11;35(7):1132-1146.e9. doi: 10.1016/j.cmet.2023.05.001. Epub 2023 May 24. Cell Metab. 2023. PMID: 37230079 Free article.
Metabolites: fuelling the immune response.
Mauro C, Diana M, Nicholas J. Mauro C, et al. Among authors: nicholas j. Clin Exp Immunol. 2022 Jun 11;208(2):129-131. doi: 10.1093/cei/uxac053. Clin Exp Immunol. 2022. PMID: 35576509 Free PMC article. No abstract available.
Sarcoidosis.
Jones NP. Jones NP. Curr Opin Ophthalmol. 2002 Dec;13(6):393-6. doi: 10.1097/00055735-200212000-00009. Curr Opin Ophthalmol. 2002. PMID: 12441843 Review.
Cannabinoid treatments in epilepsy and seizure disorders.
Devinsky O, Jones NA, Cunningham MO, Jayasekera BAP, Devore S, Whalley BJ. Devinsky O, et al. Among authors: jones na. Physiol Rev. 2024 Apr 1;104(2):591-649. doi: 10.1152/physrev.00049.2021. Epub 2023 Oct 26. Physiol Rev. 2024. PMID: 37882730 Review.
Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma.
Carbonell D, Mahajan S, Chee SP, Sobolewska B, Agrawal R, Bülow T, Gupta V, Jones NP, Accorinti M, Agarwal M, Batchelor T, Biswas J, Cimino L, tenDam-van Loon NH, de-la-Torre A, Frenkel S, Pe'er J, Kramer M, Miserocchi E, Mochizuki M, Ness T, Rosenbaum JT, Sen HN, Simion M (VRL patient), Sitter H, Vasconcelos-Santos DV, Habot-Wilner Z, Coupland SE, Pulido JS, Smith J, Thorne JE, Zierhut M; Study Group for Vitreoretinal Lymphoma Diagnostics. Carbonell D, et al. Among authors: jones np. Ocul Immunol Inflamm. 2021 Apr 3;29(3):507-520. doi: 10.1080/09273948.2021.1878233. Epub 2021 May 19. Ocul Immunol Inflamm. 2021. PMID: 34009095
273 results